Chemoinformaics analysis of 1-METHYL-4-PROP-1-EN-2-YLBENZENE
| Molecular Weight | 132.206 | nRot | 1 |
| Heavy Atom Molecular Weight | 120.11 | nRig | 20 |
| Exact Molecular Weight | 132.094 | nRing | 1 |
| Solubility: LogS | 0.21 | nHRing | 0 |
| Solubility: LogP | 0.395 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 22 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 1 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 6 |
| nHA | 0 | APOL | 24.7015 |
| nHD | 0 | BPOL | 12.0385 |
| QED | 0.824 |
| Synth | 3.545 |
| Natural Product Likeliness | 1.934 |
| NR-PPAR-gamma | 0.033 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.98 |
| HIA | 0.954 |
| CACO-2 | -5.846 |
| MDCK | 0.00000489 |
| BBB | 0.147 |
| PPB | 0.468882 |
| VDSS | 2.084 |
| FU | 0.349862 |
| CYP1A2-inh | 0.074 |
| CYP1A2-sub | 0.961 |
| CYP2c19-inh | 0.017 |
| CYP2c19-sub | 0.157 |
| CYP2c9-inh | 0.001 |
| CYP2c9-sub | 0.389 |
| CYP2d6-inh | 0.01 |
| CYP2d6-sub | 0.932 |
| CYP3a4-inh | 0.046 |
| CYP3a4-sub | 0.612 |
| CL | 3.18 |
| T12 | 0.896 |
| hERG | 0.109 |
| Ames | 0.162 |
| ROA | 0.254 |
| SkinSen | 0.176 |
| Carcinogencity | 0.021 |
| EI | 0.013 |
| Respiratory | 0.383 |
| NR-Aromatase | 0.016 |
| Antiviral | No |
| Prediction | 0.913835 |